News | October 11, 2024
OneSource unveils new brand identity at CPHI Milan
Aims to achieve CDMO sales of US$ 400 million by 2028
Aims to achieve CDMO sales of US$ 400 million by 2028
Under the licensing agreement, Alkem will carry out the clinical development of “SON-080” in India with support from Sonnet and enable global and India regulatory filings
Approval is based on Phase III INAVO120 results, showing the Itovebi (inavolisib)-based regimen more than doubled progression-free survival compared with palbociclib and fulvestrant alone in the first-line setting
WHO estimates suggest that 150 million people worldwide are affected by Trachoma
We now rank 3rd in pharmaceutical production by volume and 14th by value
India’s first trial for a novel autologous BCMA directed CAR-T cell therapy in patients with relapsed / refractory multiple myeloma
DKSH has entered into an exclusive partnership with R-Biomeds to bring the necessary medication to patients in Cambodia
Mylan and Novo Nordisk reach settlement of US patent litigation related to Ozempic
Clarity in regulatory frameworks and pathways help in preventing delays in accessing quality-assured, affordable medicines
Biotin Sublingual Spray and Melatonin Sublingual Spray to help consumers tackle health issues that come with today’s fast-paced life
Subscribe To Our Newsletter & Stay Updated
